Sort   by:  
 Page size 
UnknownEfficacy of n-3 polyunsaturated fatty acids and feasibility of optimizing preventive strategies in patients at high cardiovascular risk: rationale, design and baseline characteristics of the Rischio and Prevenzione study, a large randomised trial in general practice.
Not available
S-EPMC2909229 | biostudies-literature
UnknownDo patients' and referral centers' characteristics influence multiple sclerosis phenotypes? Results from the Italian multiple sclerosis and related disorders register.
Not available
S-EPMC9385759 | biostudies-literature
UnknownEffects of the dose of erythropoiesis stimulating agents on cardiovascular events, quality of life, and health-related costs in hemodialysis patients: the clinical evaluation of the dose of erythropoietins (C.E. DOSE) trial protocol.
Not available
S-EPMC2903576 | biostudies-literature
UnknownA novel hotspot of gelsolin instability triggers an alternative mechanism of amyloid aggregation.
Not available
S-EPMC8649582 | biostudies-literature
UnknownData monitoring roadmap. The experience of the Italian Multiple Sclerosis and Related Disorders Register.
Not available
S-EPMC10264214 | biostudies-literature
UnknownCluster Analysis Identifies Distinct Pathogenetic Patterns in C3 Glomerulopathies/Immune Complex-Mediated Membranoproliferative GN.
Not available
S-EPMC5748907 | biostudies-literature
UnknownThe role of immune suppression in COVID-19 hospitalization: clinical and epidemiological trends over three years of SARS-CoV-2 epidemic.
Not available
S-EPMC10513414 | biostudies-literature
UnknownRationale and design of the CV-PREVITAL study: an Italian multiple cohort randomised controlled trial investigating innovative digital strategies in primary cardiovascular prevention.
Not available
S-EPMC10351259 | biostudies-literature
UnknownFeasibility and effectiveness of a low cost campaign on antibiotic prescribing in Italy: community level, controlled, non-randomised trial.
Not available
S-EPMC4793446 | biostudies-literature
UnknownCommon, low-frequency, rare, and ultra-rare coding variants contribute to COVID-19 severity.
Not available
S-EPMC8661833 | biostudies-literature
Sort   by:  
 Page size